DOCS
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear under the Dr. Martens brand. The company’s product segments include Boots, Shoes, Sandals, and Bags & Other, with key silhouettes including the 1460 8-eye boot, 2976 Chelsea boot, 1461 shoe, and Blaire sandal. The brand also offers leather bags, socks, laces, and shoecare products. Dr. Martens serves consumers across three geographic regions: EMEA, Americas, and APAC. The brand was established in 1960, with the first boot produced in Wollaston, England.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Apparel Manufacturing Homepage drmartensplc.com
Sector Consumer Cyclical IR page drmartensplc.com/investors
Tags
footwear, boots, shoes, sandals, bags, consumer goods, fashion, Dr. Martens, 1460, 2976, Jadon, Bex, Sinclair, 1461, Adrian Tassel Loafer, Buzz, Lowell, Zebzag, Blaire, Gryphon, Kiev
Press page —

Metrics

Valuation  
Market cap £ 694.075M
Market cap (USD) $ 923.602M
P/E 24.97
PEG —
P/BV 2.11
P/S 0.95
P/OCF 4.86
P/FCF 5.20
Dividend yield 3.6%
Turnover / mcap —
Returns  
ROE 6.5%
ROI 3.9%
ROIC 3.9%
Profit margin 3.1%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -43.1%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) —
Debt/Equity 68.5%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -11.1%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue 764.9M 787.6M 877.1M 1B 908.3M 773M 672.2M
Net profit 23.8M 4.5M 69.2M 128.9M 181.2M 34.7M 74.8M
Free cash flow 133.5M 187.9M 149.7M 37.7M 168.9M 148.5M —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Share price 0.76 0.54 0.87 1.35 3.03 3.7 —
Price performance 12m 0.41 -0.38 -0.35 -0.55 -0.18 — —

Filed figures

Figure Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (GBP) — 59.4M 85.6M 93M 68.8M 62.4M 70.7M
↳ YoY growth +44.1% +8.6% -26.0% -9.3% +13.3%
↳ 5y CAGR +3.5%
Borrowings, current (GBP) — — — 6M 8.4M 2.4M 2.1M
Borrowings, non-current (GBP) — 282M 281M 293M 286M 246M 248M
Lease liabilities (GBP) — 84.8M 113M 152M 182M 155M 144M
Cash and deposits (GBP) 117M 114M 228M 158M 111M 156M 180M
Right-of-use assets (GBP) — 77.4M 106M 144M 174M 143M 131M
Net debt (borrowings + leases - cash) (GBP) — 253M 166M 288M 366M 248M 213M
Cash flow detail
Operating cash flow (GBP) — 159M 184M 77.3M 168M 196M 143M
Purchases of property, plant and equipment (GBP) — -10.4M -15.5M -39.6M -18.2M -8.4M -9.2M
Purchases of intangible assets (GBP) — -6.9M -9.5M -11.8M -10.2M -10.3M -2.7M
Change in receivables (cash effect) (GBP) — 800,000 -23.3M -6.6M 23M 6.3M -8.8M
Change in inventories (cash effect) (GBP) — -18.1M -18.3M -133M -1.6M 62.7M 23.5M
Change in payables (cash effect) (GBP) — 51.2M -1M -6.1M -37.7M 15.3M 5.1M
Dividends paid (cash effect) (GBP) — 0.00 -12.2M -58.4M -57.8M -9.5M -24.6M
Share buybacks (cash effect) (GBP) — — — 0.00 -50.5M 0.00 -6.7M
Interest paid (cash effect) (GBP) — — -3.5M -4.8M -19.9M -31.5M -20.9M
Income taxes paid (cash effect) (GBP) — -33.1M -41.2M -22.3M -18.8M -12.2M -10.9M
Share-based compensation (GBP) — 11.5M 5.2M 500,000 4M 7.2M 5.2M
Operating cash flow before change in receivables (GBP) — 158M 208M 83.9M 145M 190M 152M
Free cash flow (OCF - PPE - intangibles) (GBP) — 142M 159M 25.9M 140M 178M 131M
Income detail
Total comprehensive income (GBP) — 25.7M 186M 134M 68.3M 500,000 21.1M
Provision for credit losses (GBP) — — 200,000 3.9M — — —
Credit cost ratio (credit losses / average receivables) (%) — — 0.3% 4.4% — — —
Reported Jun 14, 2022 Jun 14, 2022 Jun 13, 2023 Jun 12, 2024 Jun 17, 2025 Jun 17, 2025 Jun 2, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Director/PDMR Shareholding Bull 0 Bear 0 Routine
H1 FY27 Results Bull 1 Bear 5 Results
Admission to Trading Bull 0 Bear 0 Routine

November 4, 2026 at 10:54 AM GMT

Prompts

Dr. Martens plc (ticker DOCS), listed in United Kingdom.

ETFs Holding Dr. Martens plc

ETF Weight in ETF Shares Market value As of
AVSD 0.01% 38,397 $ 27.336K Nov 16, 2026
AVDS 0.01% 76,760 $ 54.647K Nov 16, 2026
DFIS 0.01% 722,251 $ 517.239K Nov 12, 2026
AVDE 0.00% 1,269,812 $ 904.005K Nov 16, 2026